We are pleased to support the humanitarian aid efforts of the Ventilator Project which is providing community sourced HPAP ventilation solutions to several resource limited countries. Please contact us to learn how to help keep humanity first and foremost during the Covid-19 pandemic.
The latest treatment guidelines from HelmetBasedVentilation.com.
The Subsalve Oxygen Treatment Hood was developed in 2020 in response to the Covid-19 pandemic. This device is the critical patient interface to enable HPAP treatment.
HPAP, or Helmet [Hood] Positive Airway Pressure is a mode of non-invasive ventilation (NIV). Other common terms are helmet CPAP, non-invasive positive pressure ventilation (NIPPV), or simply helmet based ventilation.
HPAP treatment allows clinicians to apply PEEP from 3-25 cm H2O while elevating FiO2 for the patient. Use of a viral filter also reduces exposure risks for healthcare workers.
Subsalve Oxygen Hood Features:
SALES FOR RESEARCH, EVALUATION, AND INVESTIGATIONAL USE ONLY. IT IS THE CUSTOMERS RESPONSIBILITY TO COMPLY WITH ANY INVESTIGATIVE REQUIREMENTS. PRODUCT IS SIGNIFICANTLY EQUIVALENT TO PREDICATE DEVICES. THE PRODUCT HAS NOT BEEN FDA CLEARED OR APPROVED. PRODUCT IS IN USE FOR HUMANITARIAN AID OUTSIDE OF USA. PRODUCT DROP SHIPS FROM SUBSALVE USA.
“Compared to facemask NIV, helmet NIV reduces intubation rates from 61.5% to 18.5%”
sales & technical inquiries
Lombardi Undersea LLC
regional distributor | MENASA
The Health Bank